Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: Involvement of apoptosis and autophagy

Biochemical and Biophysical Research Communications

Volumn 444, Issue 3, 2014, Pages 376-381

  Feng, Xue ^a   Li, Ling ^b   Jiang, Hong ^a   Jiang, Keping ^a   Jin, Ye ^a   Zheng, Jianhua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Apoptosis; Autophagy; Cisplatin; Dihydroartemisinin; mTOR; Ovarian cancer

Indexed keywords

APOPTOSIS; AUTOPHAGY; CISPLATIN; DIHYDROARTEMISININ; MTOR; OVARIAN CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; AUTOPHAGY; CELL CYCLE; CELL LINE, TUMOR; CISPLATIN; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 84894086087     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.053     Document Type: Article

References (38)

1. D. Sriram, V.S. Rao, K.V. Chandrasekhara, and P. Yogeeswari Progress in the research of artemisinin and its analogues as antimalarials: an update Pharm. World Sci. 16 2004 169 180
2. V. Dhingra, K. Vishweshwar Rao, and M. Lakshmi Narasu Current status of artemisinin and its derivatives as antimalarial drugs Life Sci. 66 2000 279 300
3. S.J. Wang, Y. Gao, and H. Chen et al. Dihydroartemisinin inactivates NF-kB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo Cancer Lett. 293 2010 99 108
4. Y. Ji, Y.C. Zhang, and L.B. Pei et al. Anti-tumor effects of dihydroartemisinin on human osteosarcoma Mol. Cell Biochem. 351 2011 99 108
5. X. Gao, Z. Luo, and T. Xiang et al. Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells Tumori 97 2011 771 780
6. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J. Clin. 61 2011 212 236
7. D.K. Armstrong Relapsed ovarian cancer: challenges and management strategies for a chronic disease Oncologist 7 2002 20 28
8. D. Gozuacik, and A. Kimchi Autophagy as a cell death and tumor suppressor mechanism Oncogene 23 2004 2891 2906
9. D. Tormo, A. Checińska, and D. Alonso-Curbelo et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells Cancer Cell. 16 2009 103 114
10. R. Kang, H.J. Zeh, M.T. Lotze, and D. Tang The Beclin 1 network regulates autophagy and apoptosis Cell Death Differ. 18 2011 571 580
11. J. Cidado, and B.H. Park Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy J. Mammary Gland Biol. Neoplasia 17 2012 205 216
12. S.E. Al-Batran, M. Ducreux, and A. Ohtsu et al. MTOR as a therapeutic target in patients with gastric cancer Int. J. Cancer 130 2012 491 496
13. H.S. Choi, E.H. Jeong, and T.G. Lee et al. Autophagy inhibition with monensin enhances cell cycle arrest and apoptosis induced by mTOR or epidermal growth factor receptor inhibitors in lung cancer cells Tuberc. Respir. Dis. 75 2013 9 17
14. V.M. Adhami, D.N. Syed, N. Khan, and H. Mukhtar Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management Biochem. Pharmacol. 84 2012 1277 1281
15. H. Itamochi, and J. Kigawa Clinical trials and future potential of targeted therapy for ovarian cancer Int. J. Clin. Oncol. 17 2012 430 440
16. S. Mabuchi, T. Hisamatsu, and T. Kimura Targeting mTOR signaling pathway in ovarian cancer Curr. Med. Chem. 18 2011 2960 2968
17. X.B. Trinh, P.A. van Dam, and L.Y. Dirix et al. The rationale for mTOR inhibition in epithelial ovarian cancer Expert Opin. Invest. Drugs 18 2009 1885 1891
18. A. Yamamoto, Y. Tagawa, and T. Yoshimori et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells Cell Struct. Funct. 23 1998 33 42
19. G. Chen, Z. Ke, and M. Xu et al. Autophagy is a protective response to ethanol neurotoxicity Autophagy 8 2012 1577 1589
20. C. Marchetti, C. Pisano, and G. Facchini et al. First-line treatment of advanced ovarian cancer: current research and perspectives Expert Rev. Anticancer Ther. 10 2010 47 60
21. X.J. Huang, Z.Q. Ma, and W.P. Zhang et al. Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells J. Pharm. Pharmacol. 59 2007 849 856
22. N. Gao, A. Budhraja, and S. Cheng et al. Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo Apoptosis 16 2011 511 523
23. B. Wu, K. Hu, and S. Li et al. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer Oncol. Rep. 27 2012 101 108
24. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2012 274 293
25. J.F. Gera, I.K. Mellinghoff, and Y. Shi et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression J. Biol. Chem. 279 2004 2737 2746
26. H.C. Dan, M.J. Cooper, and P.C. Cogswell et al. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK Genes Dev. 22 2008 1490 1500
27. C.H. Yam, T.K. Fung, and R.Y. Poon Cyclin A in cell cycle control and cancer Cell Mol. Life Sci. 59 2002 1317 1326
28. R.T. Marquez, and L. Xu Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch Am. J. Cancer Res. 2 2012 214 221
29. X. Li, J. Zhang, and Z. Chen et al. Both PI3K- and mTOR-signaling pathways take part in CVB3-induced apoptosis of Hela cells DNA Cell Biol. 32 2013 359 370
30. N. Mizushima, T. Yoshimori, and B. Levine Methods in mammalian autophagy research Cell 140 2010 313 326
31. W.L. Sun, J. Chen, Y.P. Wang, and H. Zheng Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development Autophagy 7 2011 1035 1044
32. T.R. O'Donovan, G.C. O'Sullivan, and S.L. McKenna Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics Autophagy 7 2011 509 524
33. S. Jin, R.S. DiPaola, R. Mathew, and E. White Metabolic catastrophe as a means to cancer cell death J. Cell Sci. 120 2007 379 383
34. R. Mathew, C.M. Karp, and B. Beaudoin et al. Autophagy suppresses tumorigenesis through elimination of p62 Cell 37 2009 1062 1075
35. C.H. Jung, S.H. Ro, and J. Cao et al. MTOR regulation of autophagy FEBS Lett. 584 2010 1287 1295
36. M. Los, M. Mozoluk, and D. Ferrari et al. Activation and caspase mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling Mol. Biol. Cell 13 2002 978 988
37. H. Kim, J. Choi, and J. Ryu et al. Activation of autophagy during glutamate-induced HT22 cell death Biochem. Biophys. Res. Commun. 388 2009 339 344
38. W. Chaabane, S.D. User, and M. El-Gazzah et al. Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer Arch. Immunol. Ther. Exp. (Warsz) 61 2013 43 58